Camac Fund LP 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-06-17 06:24 am Sale | 2024-06-14 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 58,480 4.000% | -4,607 (-7.30%) | Filing |
2024-01-05 5:27 pm Unchanged | 2024-01-03 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 63,087 4.300% | 0 (Unchanged) | Filing |
2023-08-23 4:47 pm Purchase | 2023-08-16 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 63,087 4.300% | 10,416 (+19.77%) | Filing |
2023-08-03 4:31 pm Sale | 2023-08-01 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 52,671 3.600% | -19,837 (-27.36%) | Filing |
2023-07-05 4:54 pm Unchanged | 2023-07-03 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 72,508 8.600% | 0 (Unchanged) | Filing |
2023-05-25 3:49 pm Unchanged | 2023-05-25 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 72,508 8.600% | 0 (Unchanged) | Filing |
2023-02-21 5:15 pm Purchase | 2023-02-17 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 72,508 8.600% | 5,421 (+8.08%) | Filing |
2022-09-28 5:22 pm Purchase | 2022-09-26 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 67,087 8.200% | 9,016 (+15.53%) | Filing |
2022-08-18 09:04 am Unchanged | 2022-08-17 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 58,071 7.100% | 0 (Unchanged) | Filing |
2022-08-08 8:24 pm Purchase | 2022-08-05 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 58,071 9.800% | 13,552 (+30.44%) | Filing |
2022-08-01 3:10 pm Purchase | 2022-07-25 | 13D | Forte Biosciences, Inc. FBRX | Camac Fund LP | 44,519 7.500% | 44,519 (New Position) | Filing |